Name: UMIN ID:
Unique ID issued by UMIN | UMIN000000989 |
---|---|
Receipt number | R000001191 |
Scientific Title | Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-D05: Phase II Study of Risk Stratified Multi-drug Chemotherapy on Down Syndrome with Newly diagnosed Childhood Acute Myeloid Leukemia |
Date of disclosure of the study information | 2008/01/22 |
Last modified on | 2019/01/30 09:47:14 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2008/01/22 09:01:54 | ||
2 | Update | 2010/01/22 12:31:38 | Last name of contact person Last name of contact person |
|
3 | Update | 2012/02/06 21:29:43 | Recruitment status |
|
4 | Update | 2013/01/25 10:52:09 | Address Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
5 | Update | 2014/01/22 17:35:00 | Email |
|
6 | Update | 2014/04/23 17:37:28 | Address Last name of contact person Last name of contact person Organization Organization Division name Division name Address Address TEL |
|
7 | Update | 2014/07/23 20:03:00 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
8 | Update | 2019/01/30 09:47:14 | Stratification Dynamic allocation Blocking Concealment |